Using M&S to Evaluate Oncology Drug Dosing Blog Using M&S to Evaluate Oncology Drug Dosing There are numerous challenges in developing oncology drugs: (1) they are often very toxic which…Certara2018 年 4 月 13 日
Population Pharmacokinetics of Intravenous Linezolid in Premature Infants Publication Population Pharmacokinetics of Intravenous Linezolid in Premature Infants Danielle Pillsbury2018 年 4 月 9 日
Quantitative Analysis of Gentamicin Exposure in Neonates and Infants Calls into Question Its Current Dosing Recommendations Publication Quantitative Analysis of Gentamicin Exposure in Neonates and Infants Calls into Question Its Current Dosing Recommendations Danielle Pillsbury2018 年 4 月 1 日
An Analysis on Distribution and Inter-relationships of Biomarkers Under Rivaroxaban in Japanese Patients with Non-valvular Atrial Fibrillation (CVI ARO 1) Publication An Analysis on Distribution and Inter-relationships of Biomarkers Under Rivaroxaban in Japanese Patients with Non-valvular Atrial Fibrillation (CVI ARO 1) Danielle Pillsbury2018 年 3 月 15 日
Using Virtual Twin Technology to Predict Drug Exposure in Individual Patients On-Demand Webinar Using Virtual Twin Technology to Predict Drug Exposure in Individual Patients In this webinar, Dr. Tom Polasek, a clinical pharmacologist at Certara Strategic Consulting, explained how…Danielle Pillsbury2018 年 3 月 8 日
Skin in the Game: Mechanistic Modeling of Dermal Drug Absorption Blog Skin in the Game: Mechanistic Modeling of Dermal Drug Absorption The ability to estimate systemic exposure from dermal absorption is essential in developing new dermatological…Certara2018 年 3 月 2 日
A Randomized, Controlled Trial Evaluating the Efficacy and Safety of BTH1677 in Combination with Bevacizumab, Carboplatin, and Paclitaxel in First-line Treatment of Advanced Non-small Cell Lung Cancer Publication A Randomized, Controlled Trial Evaluating the Efficacy and Safety of BTH1677 in Combination with Bevacizumab, Carboplatin, and Paclitaxel in First-line Treatment of Advanced Non-small Cell Lung Cancer Danielle Pillsbury2018 年 2 月 27 日
Incorporation of GSTA1 Genetic Variations into a Population Pharmacokinetic Model for IV Busulfan in Pediatric Hematopoietic Stem Cell Transplantation Publication Incorporation of GSTA1 Genetic Variations into a Population Pharmacokinetic Model for IV Busulfan in Pediatric Hematopoietic Stem Cell Transplantation Danielle Pillsbury2018 年 2 月 22 日
Surveying the Lay of the Land for Modeling & Simulation for Global Regulatory Submissions Blog 勘测全球范围监管申请建模与模拟的现状 Analogous to how a geologist surveys the “lay of the land” to determine if oil…Certara2018 年 2 月 16 日
Model-informed Drug Development for Ixazomib, an Oral Proteasome Inhibitor Publication Model-informed Drug Development for Ixazomib, an Oral Proteasome Inhibitor Danielle Pillsbury2018 年 2 月 15 日